Myriad Genetics Inc (NASDAQ:MYGN)

35.49
Delayed Data
As of May 23
 +0.11 / +0.31%
Today’s Change
19.75
Today|||52-Week Range
41.57
+3.33%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2017
Quarter 3
2017
Quarter 4
2017
Quarter 1
2018
Revenue and IncomeNet Revenues200.5M190.2M194.0M193.5M
 
 
 
 
 
Cost of Goods Sold29.2M29.8M31.3M31.2M
 
 
 
 
 
Depreciation And Amortization13.3M13.2M13.1M12.9M
 
 
 
 
 
 
Operating ExpensesGross Income158.0M147.2M149.6M149.4M
 
 
 
 
 
General Expenses119.2M133.0M132.2M133.6M
 
 
 
 
 
Research And Development18.8M17.8M16.8M18.5M
 
 
 
 
 
Total Operating Expenses161.7M176.0M176.6M177.7M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income38.8M14.2M17.4M15.8M
 
 
 
 
 
Extraordinary Credit2.7M73.2M0.001.2M
 
 
 
 
Extraordinary Charge-21.7M0.00-13.0M0.00
 
 
 
Interest Expense On Debt1.2M900.0K700.0K500.0K
 
 
 
 
 
Other Expenses-100.0K-300.0K-400.0K-500.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income18.8M86.6M3.7M16.5M
 
 
 
 
 
Income Taxes-6.1M-5.6M-28.4M-5.2M
 
 
 
 
 
Minority Interest-200.0K-100.0K0.00-100.0K
 
 
 
 
Net Income12.9M81.1M32.1M11.4M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS68.2M68.6M69.3M69.8M
 
 
 
 
 
Shares To Calculate EPS Diluted68.9M70.4M71.9M72.4M
 
 
 
 
 
 
Earnings Per ShareEPS$0.19$1.15$0.45$0.16
 
 
 
 
 
EPS Diluted$0.19$1.15$0.45$0.16